Nov 6

TOBI Faculty Andrew Ittleman on the FDA’s Regulation of Stem Cells

TOBI 2017 Faculty Andrew Ittleman, JD, has published a valuable article on how the FDA should regulate human cells. This article, which appeared in The Regulatory Review, provides a brief history of the FDA's involvement in the regulation of human cells, starting with the Wall Street Journal Op-ed, "The FDA Wants to Regulate Your Cells", written by Scott Gottlieb in 2012. Gottlieb is now the Commissioner of the FDA. Ittleman analyzes Gottlieb's political history regarding the regulation of human cells,...

May 23

TOBI Faculty Publications: April 2017

Below is a resource of all April 2017 regenerative medicine publications authored by TOBI Speakers and Faculty, including alumni faculty. Each month, we compile a list with links and brief summaries of all new research and studies to keep TOBI community members informed and on the cutting edge of regenerative medicine research. Studies are listed alphabetically by TOBI Faculty names. If you are a TOBI Faculty member or alumni and would like your publications included in the TOBI monthly publications...

Mar 13

What’s New in Interventional Spine Biologics? Studies from TOBI Faculty

This year TOBI has added a workshop and cadaver lab track: Interventional Spine/Pain Management Biologics. Catch up with our Faculty publications in spine before joining us in June at TOBI 2017: 22 Feb 2018; Oxford University Press: Pain Medicine Increased Nuclear T2 Signal Intensity and Improved Function and Pain in a Patient One Year After an Intradiscal Platelet–Rich Plasma Injection Dr. Gregory Lutz of the Hospital for Special Surgery continues his remarkable research on intradiscal platelet-rich plasma (PRP) injections in this new publication...